Apoptotic cell death of human leukaemia U937 cells by ubiquinone-9 purified from Pleurotus eryngii
- Authors
- Bae, Jeen-Soo; Park, Jin Wook; Park, So Hyun; Park, Jung Bin; Rho, Yoon-Hwa; Ryu, Young Bae; Lee, Kun-Sik; Park, Ki-Hun; Bae, Young-Seuk
- Issue Date
- 2009
- Publisher
- TAYLOR & FRANCIS LTD
- Keywords
- Pleurotus eryngii; ubiquinone-9; DNA topoisomerase I inhibitor; apoptosis; human leukaemia cells; anticancer drug
- Citation
- NATURAL PRODUCT RESEARCH, v.23, no.12, pp 1112 - 1119
- Pages
- 8
- Indexed
- SCIE
SCOPUS
- Journal Title
- NATURAL PRODUCT RESEARCH
- Volume
- 23
- Number
- 12
- Start Page
- 1112
- End Page
- 1119
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/27156
- DOI
- 10.1080/14786410802417107
- ISSN
- 1478-6419
1478-6427
- Abstract
- A chloroform extract of the edible mushroom Pleurotus eryngii showed an inhibitory effect on mammalian DNA topoisomerase I. The topoisomerase I inhibitory compound was purified and identified as ubiquinone-9. Ubiquinone-9 was shown to inhibit the activity of topoisomerase I with IC50 of about 50 mu M. Concentration of 110 mu M ubiquinone-9 caused 50% growth inhibition of human leukaemia U937 cells, but not that of normal fibroblast NIH3T3 and 3Y1 cells. Ubiquinone-9-induced cell death was characterised with the cleavage of poly (ADP-ribose) polymerase and pro-caspase 3. Furthermore, ubiquinone-9 induced the fragmentation of DNA into an apoptotic DNA ladder, indicating that the inhibitor triggered apoptosis. The induction of apoptosis by ubiquinone-9 was also confirmed using flow cytometry analysis. Taken together, these results suggest that ubiquinone-9 may function by inhibiting oncogenic disease, at least in part, through the inhibition of topoisomerase I activity.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - ETC > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.